Jubilant DraxImage Inc. is a global leader in the development, manufacturing, and commercialization of radiopharmaceuticals and medical devices used for the diagnosis and treatment of disease. They provide high quality and reliable specialty products to hospital-based customers and radiopharmacies worldwide and ultimately through them patients. They are committed to Improving Life through Nuclear Medicine.
Bracco Imaging offers products and solutions for all key diagnostic imaging modalities: X-ray (including Computed Tomography, Interventional Radiology, and Cardiac Catheterization), Magnetic Resonance Imaging, Contrast Enhanced Ultrasound, and Nuclear Medicine through radioactive tracers. This portfolio is complimented by a range of medical devices and advanced administration systems.
Ionetix Corporation is the first national supplier of N-13 ammonia for use with cardiac Positron Emission Tomography (PET) imaging. N-13 Ammonia is a highly accurate myocardial perfusion imaging agent used for the detection of coronary artery disease (CAD) and is considered a gold standard for quantification of absolute coronary flow reserve (CFR). Ionetix has developed an ultra-compact, automated, unit dose N-13 ammonia production system. Ionetix will install this system directly at the hospital or clinic for on-demand dose availability, offering unprecedented access to N-13 Ammonia tracer supply.
Lantheus Medical Imaging (www.lantheus.com) is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. Key Nuclear Medicine Products: TechneLite® (Technetium Tc99m Generator); Xenon 133 (Xenon Xe 133 Gas); NEUROLITE® (Kit for the Preparation of Technetium Tc99m Bicisate for Injection).
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.
Merlino Healthcare Consulting provides professional coding and strategic health policy reimbursement advocacy, guidance and education to medical imaging organizations, healthcare professionals and industry. The company provides current, accurate, relevant, coding, coverage, payment and health care strategy and payment policy information for their clients’ specific needs, creating and transforming complex payment systems into clear and manageable business opportunities.
NorthStar Medical Radioisotopes, LLC is a nuclear medicine technology company committed to providing the U.S. with reliable and environmentally sustainable radioisotope supply solutions to meet patient needs and advance clinical research. NorthStar’s proprietary technologies include non-uranium based molybdenum-99 production methods, patented separation chemistry systems and a technology platform that allows expanded product offerings to provide solutions in diagnostic and therapeutic markets. For more information, visit: www.northstarnm.com